Koers Ekso Bionics Holdings Inc OTC Bulletin Board
Aandelen
EKSO
US2826441030
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 21,54 mln. 20,1 mln. | Omzet 2025 * | 27,81 mln. 25,94 mln. | Marktkapitalisatie | 19,99 mln. 18,65 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,46 mln. | Nettowinst (verlies) 2025 * | -4 mln. -3,73 mln. | EV/omzet 2024 * | 0,93 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,72 x |
K/w-verhouding 2024 * |
-2,56
x | K/w-verhouding 2025 * |
-5,79
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,79% |
Recentste transcriptie over Ekso Bionics Holdings Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 01-04-21 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 01-05-17 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 56 | 25-12-21 |
Mary Cloyd
BRD | Director/Board Member | 69 | 29-12-20 |
Charles Li
BRD | Director/Board Member | 39 | 11-03-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,01% | 218 mld. | |
+9,85% | 189 mld. | |
+27,51% | 151 mld. | |
+31,79% | 113 mld. | |
-0,15% | 64,02 mld. | |
+13,93% | 52,6 mld. | |
+1,85% | 49,85 mld. | |
-5,18% | 37,89 mld. | |
+0,30% | 34,92 mld. |